These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10906838)

  • 1. Physician prescribing of sterile injection equipment to prevent HIV infection: time for action.
    Burris S; Lurie P; Abrahamson D; Rich JD
    Ann Intern Med; 2000 Aug; 133(3):218-26. PubMed ID: 10906838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?
    Lurie P; Jones TS; Foley J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S45-51. PubMed ID: 9663623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The legality of selling or giving syringes to injection drug users.
    Burris S; Vernick JS; Ditzler A; Strathdee S
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S13-8. PubMed ID: 12489604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health.
    Gostin LO
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S60-70. PubMed ID: 9663626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The needle-borne HIV epidemic: causes and public health responses.
    Gostin L
    Behav Sci Law; 1991; 9(3):287-304. PubMed ID: 10148824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterile injection equipment to prevent HIV infection.
    Robertson R
    Ann Intern Med; 2001 Aug; 135(4):299. PubMed ID: 11511145
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescribing syringes to prevent HIV: a survey of infectious disease and addiction medicine physicians in Rhode Island.
    Rich JD; Whitlock TL; Towe CW; McKenzie M; Runarsdottir V; Aboagye-Kumi M; Burris S
    Subst Use Misuse; 2001 Apr; 36(5):535-50. PubMed ID: 11419486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A national physician survey on prescribing syringes as an HIV prevention measure.
    Macalino GE; Sachdev DD; Rich JD; Becker C; Tan LJ; Beletsky L; Burris S
    Subst Abuse Treat Prev Policy; 2009 Jun; 4():13. PubMed ID: 19505336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should pharmacists sell sterile syringes to injection drug users?
    Jones TS; Taussig J
    J Am Pharm Assoc (Wash); 1999; 39(1):8-10. PubMed ID: 9990178
    [No Abstract]   [Full Text] [Related]  

  • 10. Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law.
    Case P; Beckett GA; Jones TS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S94-101. PubMed ID: 9663631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liability for prescribing intravenous injection equipment to i.v. drug users.
    Mehlman MJ
    Health Matrix Clevel; 2001; 11(1):73-84. PubMed ID: 11345678
    [No Abstract]   [Full Text] [Related]  

  • 13. Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon.
    Ghaddar A; Nassar K; Elsoury G
    Subst Use Misuse; 2017 Sep; 52(11):1420-1428. PubMed ID: 28430013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A syringe prescription program to prevent infectious disease and improve health of injection drug users.
    Rich JD; McKenzie M; Macalino GE; Taylor LE; Sanford-Colby S; Wolf F; McNamara S; Mehrotra M; Stein MD
    J Urban Health; 2004 Mar; 81(1):122-34. PubMed ID: 15047791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In New York City, syringe laws and regulations deter physicians and pharmacists from prescribing and selling syringes to persons who may be injection drug users.
    Lazzarini Z; Schoenbaum EE; O'Neill CH
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S141-3. PubMed ID: 9663639
    [No Abstract]   [Full Text] [Related]  

  • 16. An analysis of ethical issues in prescribing and dispensing syringes to injection drug users.
    Lazzarini Z
    Health Matrix Clevel; 2001; 11(1):85-128. PubMed ID: 11345679
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of sterile syringes and aseptic drug preparation are important components of HIV prevention among injection drug users.
    Jones TS; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S1-5. PubMed ID: 9663616
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
    Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
    J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syringe prescription to prevent HIV infection in Rhode Island: a case study.
    Rich JD; Macalino GE; McKenzie M; Taylor LE; Burris S
    Am J Public Health; 2001 May; 91(5):699-700. PubMed ID: 11344871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harm reduction in the health care system: the legality of prescribing and dispensing syringes to drug users.
    Burris S; Lurie P; Ng M
    Health Matrix Clevel; 2001; 11(1):5-64. PubMed ID: 11345676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.